These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28559424)

  • 21. The GPCR-β-arrestin complex allosterically activates C-Raf by binding its amino terminus.
    Zang Y; Kahsai AW; Pakharukova N; Huang LY; Lefkowitz RJ
    J Biol Chem; 2021 Dec; 297(6):101369. PubMed ID: 34757127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7.
    Puchert M; Obst J; Koch C; Zieger K; Engele J
    Cytokine; 2020 Jan; 125():154809. PubMed ID: 31437604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gα
    Wang J; Hanada K; Staus DP; Makara MA; Dahal GR; Chen Q; Ahles A; Engelhardt S; Rockman HA
    Nat Commun; 2017 Nov; 8(1):1706. PubMed ID: 29167435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Mechanisms of Biased and Probe-Dependent Signaling at CXC-Motif Chemokine Receptor CXCR3 Induced by Negative Allosteric Modulators.
    Brox R; Milanos L; Saleh N; Baumeister P; Buschauer A; Hofmann D; Heinrich MR; Clark T; Tschammer N
    Mol Pharmacol; 2018 Apr; 93(4):309-322. PubMed ID: 29343553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensors.
    Namkung Y; LeGouill C; Kumar S; Cao Y; Teixeira LB; Lukasheva V; Giubilaro J; Simões SC; Longpré JM; Devost D; Hébert TE; Piñeyro G; Leduc R; Costa-Neto CM; Bouvier M; Laporte SA
    Sci Signal; 2018 Dec; 11(559):. PubMed ID: 30514808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-alpha2b restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by modulating CXC receptor ligand interaction.
    Chakraborty K; Bose A; Pal S; Chattopadhyay U; Baral R
    J Interferon Cytokine Res; 2008 Aug; 28(8):487-99. PubMed ID: 18729739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCR3 ligands in disease and therapy.
    Van Raemdonck K; Van den Steen PE; Liekens S; Van Damme J; Struyf S
    Cytokine Growth Factor Rev; 2015 Jun; 26(3):311-27. PubMed ID: 25498524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils.
    Gabl M; Holdfeldt A; Sundqvist M; Lomei J; Dahlgren C; Forsman H
    Biochem Pharmacol; 2017 Dec; 145():114-122. PubMed ID: 28855087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning, characterization and gene expression of murrel CXC chemokine receptor 3a against sodium nitrite acute toxicity and microbial pathogens.
    Bhatt P; Chaurasia MK; Palanisamy R; Kumaresan V; Arasu A; Sathyamoorthi A; Gnanam AJ; Kasi M; Pasupuleti M; Ramaswamy H; Arockiaraj J
    Fish Shellfish Immunol; 2014 Aug; 39(2):245-53. PubMed ID: 24861891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B.
    D'Uonnolo G; Reynders N; Meyrath M; Abboud D; Uchański T; Laeremans T; Volkman BF; Janji B; Hanson J; Szpakowska M; Chevigné A
    Front Immunol; 2022; 13():868579. PubMed ID: 35720349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential role of CXCR3 in proliferation and invasion of prostate cancer cells.
    Shen D; Cao X
    Int J Clin Exp Pathol; 2015; 8(7):8091-8. PubMed ID: 26339376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arrestin interactions with G protein-coupled receptors.
    Lohse MJ; Hoffmann C
    Handb Exp Pharmacol; 2014; 219():15-56. PubMed ID: 24292823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis?
    Urra S; Fischer MC; Martínez JR; Véliz L; Orellana P; Solar A; Bohmwald K; Kalergis A; Riedel C; Corvalán AH; Roa JC; Fuentealba R; Cáceres CJ; López-Lastra M; León A; Droppelmann N; González HE
    Oncotarget; 2018 Jan; 9(2):2445-2467. PubMed ID: 29416784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor, Ligand and Transducer Contributions to Dopamine D2 Receptor Functional Selectivity.
    Peterson SM; Pack TF; Caron MG
    PLoS One; 2015; 10(10):e0141637. PubMed ID: 26516769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biased signaling regulates the pleiotropic effects of the urotensin II receptor to modulate its cellular behaviors.
    Brulé C; Perzo N; Joubert JE; Sainsily X; Leduc R; Castel H; Prézeau L
    FASEB J; 2014 Dec; 28(12):5148-62. PubMed ID: 25183668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of Chemokine N-Terminal Modification on Biased Agonism at the Chemokine Receptor CCR1.
    Sanchez J; Lane JR; Canals M; Stone MJ
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
    Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of β-Arrestin Recruitment at GPCRs Using the Tango Assay.
    Laroche G; Giguère PM
    Methods Mol Biol; 2019; 1947():257-267. PubMed ID: 30969421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCL4L1 and CXCL4 signaling in human lymphatic and microvascular endothelial cells and activated lymphocytes: involvement of mitogen-activated protein (MAP) kinases, Src and p70S6 kinase.
    Van Raemdonck K; Gouwy M; Lepers SA; Van Damme J; Struyf S
    Angiogenesis; 2014 Jul; 17(3):631-40. PubMed ID: 24469069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.
    Wu Q; Dhir R; Wells A
    Mol Cancer; 2012 Jan; 11():3. PubMed ID: 22236567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.